Editors' Picks  by unknown
editors' picks
2326 Journal of Investigative Dermatology (2009), Volume 129 © 2009 The Society for Investigative Dermatology
Revelation of a latent niche
Because the interactions between stem cells and their 
niches appear to be critical in tumor initiation, McGovern 
and colleagues employed the Caenorhabditis elegans 
hermaphro dite germ line to investigate this interplay. In 
proximal proliferation mutants, which exhibit hyper plasia 
with two germ-line proliferation centers, ectopic germ 
cell proliferation was driven by a so-called “latent niche.” 
This mechanism involves a cell type that does not typically 
contact the stem cells but that under certain conditions can 
promote the self-renewal and proliferation of these cells. In 
addition, this latent niche function relies on inappropriate 
GLP-1/Notch signaling, which promotes and maintains prox-
imal germ-line tumors. This mechanism may proceed without 
genetic changes in the tumor cell or tumor-promoting cells. 
Future investigations are necessary to implicate this molec-
ular mechanism in the initiation or metastasis of tumors in 
humans. (Proc Natl Acad Sci USA 106:11617–22, 2009)
Collagen special delivery
Current therapies for the skin-blistering disease epiderm olysis 
bullosa, which results from mutations in the collagen VII gene, 
involve symptom management and minimization of environ-
mental factors. The development of more causal treatments 
is therefore imperative to improve the lives of these patients. 
Kern and colleagues demonstrated a long-lasting effect of 
fibroblast therapy in mice. Intradermal injection of primary 
fibroblasts into collagen VII hypomorphic mice resulted in the 
deposition of newly synthesized collagen VII at the dermal–
epidermal junction zone. This collagen, which remained 
stable for more than 100 days despite gradual apoptosis of 
the fibroblasts after 21 days, was competent for fibril genera-
tion and aggregation, yielding dramatic improvements to the 
skin integrity. Interestingly, the clinical improvement of the 
disease symptoms did not require full restoration of collagen 
levels. Thus, these studies detail the remarkable long-term 
effects of collagen replacement following fibroblast injection 
in mice and support the use of such fibroblast therapy for skin 
fragility diseases in humans. (Mol Ther, published online 30 
June 2009; doi:10.1038/mt.2009.144)
In the driver’s seat
“Atopic march” describes the development of asthma in as 
many as 70% of patients with severe atopic dermatitis (AD), 
a disease caused by mutations in the critical epidermal bar-
rier component filaggrin. To explore the underlying cause of 
this progression, Demehri and colleagues examined the risk 
of asthma in mice following inactivation of signaling through 
Notch, a key regulator of the keratinocyte barrier organization. 
Indeed, these mice exhibited AD-like allergic inflammation 
as well as a subsequent susceptibility to asthma. Furthermore, 
thymic stromal lymphopoietin (TSLP), a general barrier defect 
biomarker and an early player in inflammation, was shown to 
be both necessary and sufficient for the asthmatic phenotype 
in these animals. Thus, system ically available TSLP may be 
the key driver in the atopic march and might serve as a thera-
peutic target to lower the incidence of asthma in AD patients. 
(PLoS Biol 7:e1000067, 2009)
RIP switch
The cell-death processes apoptosis and necrosis are regulated 
by different pathways, although some interconnectivity has 
been documented. Caspase inhibition often shifts apoptosis 
to necrosis. Receptors that contain death domains induce 
regulated necrosis via receptor-interacting protein 1 (RIP1) 
kinase activity; however, the apoptosis/necrosis molecular 
switch is not known. Zhang and colleagues identified the 
RIP3 protein kinase as a critical protein involved in the 
determination of cell-death pathway in NIH 3T3 cells fol-
lowing tumor necrosis factor (TNF) stimulation or caspase 
inhibition. RIP3 did not alter RIP1-mediated apoptosis but 
proved necessary for RIP1-mediated necrosis. Importantly, 
determination of RIP3-interacting factors revealed that RIP3 
may function in this regulation via activation of metabolic 
enzymes that regulate reactive oxygen species in response 
to TNF. Inhibition of RIP3 may therefore be useful in treat-
ing diseases that are associated with necrosis, such as dia-
betes, acute pancreatitis, and cerebral ischemia. (Science 
325:332–6, 2009)
Sialoadhesin dialogue
CD4+ CD25+ regulatory T cells (T-regs) have been implicated 
in the suppression of autoimmune responses via interactions 
among T-regs, effector T cells, and antigen-presenting 
cells such as macrophages. Using murine experimental 
autoimmune encephalomyelitis (EAE) as a model for auto-
immune disease, Wu and colleagues examined the role of 
sialoadhesin (Sn), a sialic acid–binding molecule on macro-
phages, in T-reg function. Sn-positive macrophages have been 
observed in the central nervous system during EAE. Sn knock-
out animals exhibited a significant decrease in EAE severity 
and incidence. These mice also had a significant increase in 
T-regs and a reduction in effector-T-cell number within the 
central nervous system. In addition, a subpopulation of T-regs 
was found to express Sn ligands. Together, these data indi-
cate that macrophages expressing Sn negatively regulate the 
expansion of T-regs via direct cell–cell contact through the Sn 
molecules. Thus, a loss of Sn-positive macrophages increases 
the proliferation of T-regs and decreases the number of 
responsive effector T cells, resulting in a milder autoimmune 
response. (J Immunol 182:6508–16, 2009)
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